Search research articles
Contact Us
Filters
Showing results (31-40 of 68) with videos related to
Page
of 7
Sort By:
Circulation. Heart Failure
|
February 22, 2023
Disentangling the Pulmonary Capillary Wedge Pressure From the Pulmonary Artery Pressure as the Hemodynamic Underpinning of Bendopnea
Jennifer T Thibodeau, Goutham Ravipati, David D Pham, et al.
Cardiology and Therapy
|
March 7, 2024
Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset
Richard Channick, Kelly M Chin, Vallerie V McLaughlin, et al.
Advances in Therapy
|
November 19, 2025
Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS Studies
Lana D Melendres-Groves, Richard N Channick, Kelly M Chin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
February 2, 2021
Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE
Nick H Kim, Anna R Hemnes, Murali M Chakinala, et al.
The European Respiratory Journal
|
September 10, 2024
MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH study
Marc Humbert, Paul M Hassoun, Kelly M Chin, et al.
Pulmonary Therapy
|
January 6, 2024
Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies
Nick H Kim, Kelly M Chin, Vallerie V McLaughlin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
October 1, 2023
Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry)
Vallerie McLaughlin, Harrison W Farber, Kristin B Highland, et al.
Respiratory Research
|
February 4, 2021
Temporarily switching from oral to intravenous selexipag in patients with pulmonary arterial hypertension: safety, tolerability, and pharmacokinetic results from an open-label, phase III study
Hans Klose, Kelly M Chin, Ralf Ewert, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
May 15, 2025
Corrigendum to ''Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry)'' [J Heart Lung Transplant 43 (2024) 272-283]
Vallerie McLaughlin, Harrison W Farber, Kristin B Highland, et al.
The European Respiratory Journal
|
November 13, 2025
Long-term safety and tolerability of frespaciguat: INSIGNIA-PAH extension
Marc Humbert, Paul M Hassoun, Kelly M Chin, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 68) with videos related to
Sort By:
Page
of 7
Circulation. Heart Failure
|
February 22, 2023
Disentangling the Pulmonary Capillary Wedge Pressure From the Pulmonary Artery Pressure as the Hemodynamic Underpinning of Bendopnea
Jennifer T Thibodeau, Goutham Ravipati, David D Pham, et al.
Cardiology and Therapy
|
March 7, 2024
Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset
Richard Channick, Kelly M Chin, Vallerie V McLaughlin, et al.
Advances in Therapy
|
November 19, 2025
Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS Studies
Lana D Melendres-Groves, Richard N Channick, Kelly M Chin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
February 2, 2021
Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE
Nick H Kim, Anna R Hemnes, Murali M Chakinala, et al.
The European Respiratory Journal
|
September 10, 2024
MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH study
Marc Humbert, Paul M Hassoun, Kelly M Chin, et al.
Pulmonary Therapy
|
January 6, 2024
Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies
Nick H Kim, Kelly M Chin, Vallerie V McLaughlin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
October 1, 2023
Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry)
Vallerie McLaughlin, Harrison W Farber, Kristin B Highland, et al.
Respiratory Research
|
February 4, 2021
Temporarily switching from oral to intravenous selexipag in patients with pulmonary arterial hypertension: safety, tolerability, and pharmacokinetic results from an open-label, phase III study
Hans Klose, Kelly M Chin, Ralf Ewert, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
May 15, 2025
Corrigendum to ''Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry)'' [J Heart Lung Transplant 43 (2024) 272-283]
Vallerie McLaughlin, Harrison W Farber, Kristin B Highland, et al.
The European Respiratory Journal
|
November 13, 2025
Long-term safety and tolerability of frespaciguat: INSIGNIA-PAH extension
Marc Humbert, Paul M Hassoun, Kelly M Chin, et al.
Page
of 7